United States - English - NLM (National Library of Medicine)

forest pharmaceuticals, inc. - flunisolide hemihydrate (unii: qk4dys664x) (flunisolide - unii:qk4dys664x) - aerosol, metered - 80 ug - aerospan inhalation aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. aerospan inhalation aerosol is also indicated for asthma patients requiring oral corticosteroid therapy, where adding aerospan inhalation aerosol may reduce or eliminate the need for oral corticosteroids. aerospan inhalation aerosol is not indicated for the relief of acute bronchospasm. aerospan inhalation aerosol is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. hypersensitivity to flunisolide or any of the ingredients of this preparation contraindicates the use of aerospan inhalation aerosol.

Australia - English - Department of Health (Therapeutic Goods Administration)

bird healthcare pty ltd - 35142 - aerosol face mask, rebreathing - intended to be placed over the nose and mouth to deliver aerosolized particles to a patient's airway.

United States - English - NLM (National Library of Medicine)

seroyal usa - anaerococcus tetradius (unii: 7q9dhh4fgg) (anaerococcus tetradius - unii:7q9dhh4fgg), influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), moraxella catarrhalis subsp. catarrhalis (unii: 1x259jgo78) (moraxella catarrhalis subsp. catarrhalis - unii:1x259jgo78) - anaerococcus tetradius 200 [hp_c] - uses for the temporary relief of cold and flu-like symptoms do not use if you have ever had an allergic reaction to this product or any of its ingredients. uses for the temporary relief of cold and flu-like symptoms. directions adults and adolescents (12 years and older): at the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. if symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner. children (6-11 years): take under the direction of your healthcare practitioner.

Australia - English - Department of Health (Therapeutic Goods Administration)

aero healthcare - 61694 - skin-cleaning wipe, non-sterile - non-sterile device consisting of an absorbent fabric pre-soaked in a liquid solution (e.g. povidone iodine)intended for cleaning a localized body surface before a procedure or device application, and/or to maintain skin hygiene. it is commonly known as a wet wipe and is normally available [non-prescription]over-the-counter (otc) for use in the home or healthcare facility. this is a single-use device.

Australia - English - Department of Health (Therapeutic Goods Administration)

aero healthcare - 11879 - glove, - a device acting as a protective barrier between the user's hand or hands and the external environment. this will typically be, e.g. an infection barrier between patient and healthcare provider or as an overall protection of the skin of the hand and fingers. the device may also provide therapeutic protection.

Australia - English - Department of Health (Therapeutic Goods Administration)

aero healthcare - 35492 - gown, isolation, single use - a multipurpose garment worn by healthcare providers or visitors to isolate them from the patient. the isolation gown protects the patient, from the transfer of infectious agents carried by the healthcare provider or visitor; or it can protect the healthcare provider or visitor from a contagious agent which has infected the patient. this is a disposable garment.

Australia - English - Department of Health (Therapeutic Goods Administration)

aero healthcare - 11961 - shield, face - a clear, transparent guard worn over the face to protect the healthcare worker from blood and other body fluid splashes while performing a clinical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

clifford hallam healthcare pty ltd - 35142 - aerosol face mask, rebreathing - to deliver aerosolised particles into a patient's airway.

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - glycopyrrolate (unii: v92so9wp2i) (glycopyrronium - unii:a14fb57v1d), formoterol fumarate (unii: w34shf8j2k) (formoterol - unii:5zz84gcw8b) - glycopyrrolate 9 ug - bevespi aerosphere is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (copd). limitations of use: bevespi aerosphere is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see warnings and precautions (5.1, 5.2)] . bevespi aerosphere is contraindicated in: risk summary   there are no adequate and well-controlled trials of bevespi aerosphere or its individual components, glycopyrrolate and formoterol fumarate, in pregnant women to inform a drug-associated risk. in animal reproduction studies, glycopyrrolate alone, administered by the subcutaneous route in rats and rabbits, did not cause structural abnormalities or affect fetal survival at exposures approximately 2700 and 5400 times from the maximum recommended human daily inhalation dose (mrhdid), respectively. glycopyrrolate had no effects on the physical, functional, and behavioral development of rat pups with exposures up to 2700 times the mrhdid. formoterol fumarate alone, admin

United States - English - NLM (National Library of Medicine)

aero healthcare, llc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), benzethonium chloride (unii: ph41d05744) (benzethonium - unii:1vu15b70bp) - topical antiseptic topical anesthetic  for help in control of superficial bleeding and temporary relief of pain of: - minor cuts and scrapes - minor burns - in or near mucous membranes - on serious burns - on raw surfaces - on deep puncture wounds - for a prolonged period of time - on blistered areas - on a large portion of the body - on animal bites - redness, swelling, or irritation occurs - infection occurs - condition persists or worsens - symptoms persist for more than 7 days